HEALTHCARE ASSOCIATED INFECTION PREVENTION
RESEARCHER PROFILE
Professor Philip Russo (Filmed June 2024)
Professor of Nursing
Director of Research, Nursing & Midwifery, Monash University &
Director of Nursing Research, Cabrini Health, Melbourne, Australia
Professor Russo is Director of Research, Nursing and Midwifery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia and Director of Nursing Research, Cabrini Health.
Professor Russo is an internationally regarded expert in healthcare associated infection prevention, and led the recently completed the Australian National Healthcare Associated Infection Point Prevalence Survey, the first in Australia for 34 years. He is also Past President of the Australasian College for Infection Prevention and Control (ACIPC), the peak body for Infection Prevention and Control professionals in the Australasian region.
Aside from his role at ACIPC, other leadership and engagement activities include; former Deputy Chair of the Infection Control Expert Group (COVID-19), a member of the National COVID-19 Clinical Evidence Taskforce Steering Committee, the National Health and Medical Research Council Infection Control Guidelines Advisory Committee, and the Healthcare Associated Infection Advisory Committee for the Australian Commission on Safety and Quality in Health Care.
Professor Russo is the recipient of a National Health and Medical Research Early Career Fellowship and has attracted research funding from government, industry, philanthropic and academic sources. He has presented at both national and international conferences, authored over 100 peer reviewed articles and several book chapters.
-
Health and economic burden of interstitial lung diseases
Dr Cox’s main research interests focus on respiratory diseases and primarily on the economic burden and economic evaluation of interventions and treatments for their management. She earned her PhD from the University of Tasmania where her doctoral research examined the health and economic burden of idiopathic pulmonary fibrosis (IPF) in Australia, one component of the NHMRC Centre for Research Excellence for Pulmonary Fibrosis, a national project implemented alongside the Australian IPF Registry and the Lung Foundation Australia. This research provided the first epidemiological profile and first costing estimates of the economic burden of the disease in Australia, providing essential evidence for health service reimbursement policies.
-
Exercise therapy for metabolic dysfunction-associated steatotic liver disease
Dr Shelley Keating is a Senior Lecturer in Clinical Exercise Physiology and Accredited Exercise Physiologist from the School of Human Movement and Nutrition Sciences at the University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating’s research centres on the utility of exercise as a therapy for obesity and related cardiometabolic conditions, notably metabolic dysfunction-associated steatotic liver disease (MASLD).
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
